IDEAS home Printed from https://ideas.repec.org/a/spr/ariqol/v12y2017i3d10.1007_s11482-016-9485-4.html
   My bibliography  Save this article

Comorbid Social Phobia and Major Depressive Disorder: the Influence of Remission from Depression on Quality of Life and Functioning

Author

Listed:
  • Alexander Joseph Steiner

    (Department of Psychology, California School of Professional Psychology at Alliant International University
    Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center)

  • Stephanie Marie Wright

    (Department of Psychology, California School of Professional Psychology at Alliant International University)

  • Taylor Kuhn

    (University of California Los Angeles)

  • Waguih William IsHak

    (Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center
    University of California Los Angeles)

Abstract

Social phobia (SP) and major depressive disorder (MDD) are frequently concurrent, which negatively affects quality of life (QOL), functioning, and depressive symptom severity. We hypothesized individuals with comorbid SP and MDD (MDD + SP) would have worse treatment outcomes than those with MDD alone (MDDnoSP), but that both groups would have significant responses to treatment, and those who achieved MDD remission would have the best increases in QOL and functioning. We analyzed data for 2280 adults who received citalopram monotherapy in phase 1 of the NIH-funded Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Participants (82 MDD + SP and 2198 MDDnoSP) with complete entry and exit scores across QOL, functioning, and depressive symptom severity were examined. MDD remission status following treatment was determined. Patient-reported QOL and functioning scores were classified as within-normal or severely-impaired. No significant between-group differences were observed across all outcomes at entry or exit. Both groups experienced significant improvements in QOL and functioning (all p values .77). Although non-significant, the MDD + SP group was more likely to achieve within-normal scores and MDD remission post-treatment. Findings were interesting as we initially expected the MDD + SP participants to have worse outcomes, yet those with MDD alone had a more chronic course. Regardless, participants who were able to achieve MDD remission post-treatment had significantly better improvements in QOL and functioning. Accordingly, researchers and clinicians should utilize QOL and functioning measures when examining treatment effectiveness, while also considering the role of remission from major depressive disorder on quality of life.

Suggested Citation

  • Alexander Joseph Steiner & Stephanie Marie Wright & Taylor Kuhn & Waguih William IsHak, 2017. "Comorbid Social Phobia and Major Depressive Disorder: the Influence of Remission from Depression on Quality of Life and Functioning," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 12(3), pages 719-736, September.
  • Handle: RePEc:spr:ariqol:v:12:y:2017:i:3:d:10.1007_s11482-016-9485-4
    DOI: 10.1007/s11482-016-9485-4
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s11482-016-9485-4
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s11482-016-9485-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Christian WEISMAYER, 2022. "Applied Research in Quality of Life: A Computational Literature Review," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 17(3), pages 1433-1458, June.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:ariqol:v:12:y:2017:i:3:d:10.1007_s11482-016-9485-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.